What's New on the FDA Drugs Site
October 17, 2016
- CDER Statement: Proposed rule to amend the list of drug products that may not be compounded because they have been withdrawn or removed from the market for safety and effectiveness reasons
- Drug Firm Annual Registration Status Download File (updated)
- Drug Firm Annual Registration Status (updated)
- FDA Drug Shortages
- Asparaginase Erwinia Chrysanthemi (Erwinaze) (Updated - Currently in Shortage)
- Docetaxel Injection (New - Discontinuation)
- Scopolamine (Transderm Scop) Transdermal System Patch (Updated - Currently in Shortage)
- Sumatriptan (Sumavel DosePro) Injection (New - Discontinuation)
- Water-Miscible Vitamin A Palmitate (Aquasol A Parenteral) (Updated - Resolved)
- FDA-PDS Symposium, November 29, 2016
- Generic Drug Review Dashboard Report as of October 1, 2016 (PDF - 302KB)
- Methylphenidate Hydrochloride Extended Release Tablets (generic Concerta) made by Mallinckrodt and Kudco (updated)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario